MDT

100.66

-0.33%↓

A

136.08

+0.89%↑

VEEV

223.84

+0.94%↑

HQY

85.31

+1.39%↑

NEOG

10.02

+2.14%↑

MDT

100.66

-0.33%↓

A

136.08

+0.89%↑

VEEV

223.84

+0.94%↑

HQY

85.31

+1.39%↑

NEOG

10.02

+2.14%↑

MDT

100.66

-0.33%↓

A

136.08

+0.89%↑

VEEV

223.84

+0.94%↑

HQY

85.31

+1.39%↑

NEOG

10.02

+2.14%↑

MDT

100.66

-0.33%↓

A

136.08

+0.89%↑

VEEV

223.84

+0.94%↑

HQY

85.31

+1.39%↑

NEOG

10.02

+2.14%↑

MDT

100.66

-0.33%↓

A

136.08

+0.89%↑

VEEV

223.84

+0.94%↑

HQY

85.31

+1.39%↑

NEOG

10.02

+2.14%↑

Search

Cencora Inc

Open

SectorHealthcare

354.72 0.51

Overview

Share price change

24h

Current

Min

353.49

Max

356.41

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

44.635

89.037

EPS

3.84

Dividend yield

0.62

Profit margin

-0.406

Employees

47,000

EBITDA

-1.1B

183M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.51% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.62%

2.18%

Next Earnings

4 lut 2026

Next Dividend date

2 mar 2026

Next Ex Dividend date

13 lut 2026

Market Stats

By TradingEconomics

Market Cap

2.7B

69B

Previous open

354.21

Previous close

354.72

News Sentiment

By Acuity

58%

42%

292 / 352 Ranking in Healthcare

Cencora Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 sty 2026, 23:49 UTC

Market Talk

Oil Falls on Possible Technical Correction -- Market Talk

25 sty 2026, 23:43 UTC

Market Talk

Correction to Gold Rises Above $5000/oz Market Talk

25 sty 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25 sty 2026, 23:43 UTC

Market Talk

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

25 sty 2026, 23:36 UTC

Market Talk

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

25 sty 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

25 sty 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

Companies Had Been Discussing Roughly $30B Deal -- WSJ

25 sty 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

24 sty 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

24 sty 2026, 09:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

24 sty 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 sty 2026, 09:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

24 sty 2026, 06:18 UTC

Acquisitions, Mergers, Takeovers

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 sty 2026, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

23 sty 2026, 22:30 UTC

Market Talk

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 sty 2026, 22:03 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 sty 2026, 21:52 UTC

Earnings
Acquisitions, Mergers, Takeovers

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 sty 2026, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

23 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 sty 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

23 sty 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 sty 2026, 21:39 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 sty 2026, 21:15 UTC

Acquisitions, Mergers, Takeovers

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 sty 2026, 21:12 UTC

Earnings

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 sty 2026, 20:31 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 sty 2026, 20:12 UTC

Market Talk

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 sty 2026, 20:07 UTC

Market Talk

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 sty 2026, 19:36 UTC

Market Talk

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 sty 2026, 19:30 UTC

Market Talk
Earnings

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 sty 2026, 19:18 UTC

Market Talk

Gold and Silver Step Up to More Records -- Market Talk

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

15.51% upside

12 Months Forecast

Average 408.3 USD  15.51%

High 440 USD

Low 371 USD

Based on 11 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

292 / 352 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat